Fitocomplexo

Plenusvirax®

Among these different and effective bioactive compounds extracts generated by this technology, Phytoplenus produces an extract with immunostimulating properties from the plant Echinacea purpurea (L.) Moench. The bioactive compounds of Echinacea purpurea are represented by Alkamides derivatives of decanoic and undecanoic acids, and phenolic derivatives such as caftaric, chlorogenic, and chicoric acid.

The extract of Echinacea purpurea produced by Phytoplenus has immunostimulatory effects on the immune system and acts functionally both in a non-specific and in a specific way. Non-specific effects include increased proliferation of macrophages and phagocytosis, as well as secretion of interferon, tumor necrosis factor and interleukin-1 (in vitro and in vivo). The specific immune responses include the activation of alternative pathway complement components through high levels/activity of T lymphocytes and natural killer cells (NK). It is believed that Echinacea purpurea is the vegetable specie that has the strongest immunostimulation power, which depends on the dosage and on the frequency of administration. It has been observed that taking Echinacea purpurea for seven days significantly increases the basal levels of lymphocytes, monocytes and neutrophils, as well as CD16 and natural killer cells (NK).

The extract of Echinacea purpurea produced by Phytoplenus Technology promotes an effective reduction of dermal lesions through the immunostimulation of macrophages and other immunocompetent cells that important in the healing process. It also has an adjuvant action against opportunistic viral infections, resulting in an efficient tissue repair. The various bioactive compounds present in the extract – especially alkamides derived from decanoic and undecanoic acids, and phenolic acid derivatives such as chlorogenic, caftaric and chicoric acids and polysaccharides – are immunological and healing boosters, which help the cellular and biochemical events to follow their normal course, thus preventing an exacerbated release of pro-inflammatory mediators such as prostaglandins and other eicosanoids, which usually cause inflammation and hyperalgesic pain.

In this context, the Echinacea purpurea extract produced by Phytoplenus Technology gathers all the functions mentioned above on the process of topical immunomodulation and tissue repair in a single extract, presenting a special and more effective preparation in comparison to conventional products.

ATTENTION!

Phytoplenus Hydroglycolic Extract of Echinacea purpurea 6% (PSA-EPV)is a pharmaceutical ingredient, and not a medication. The medication made of Phytoplenus Extract can only be obtained through a doctor’s prescription at pharmacies certified by Phytoplenus, as stated above.

TECHNICAL INFORMATION FOR PHYTOPLENUS ECHINACEA EXTRACT

ClassCOMPONENT OF PHYTO-THERAPEUTIC MEDICATION
Official Botanical NameEchinacea purpurea (L.) Moench
Popular NameEchinacea
FamilyAsteraceae
Part of Plant UsedFlowers and aerial portions
Commercial NameExtrato Hidroglicólico de Echinacea purpurea 6%
Manufactured byPhytoplenus Bioativos S.A.
Rua Wanda dos Santos Mullmann, 1501
CEP 83323-123 — Pinhais — PR
CNPJ/MF Nº 10.704.205/0001-01
Information:
hone/Fax: (41) 3667-1717
E-mail: [email protected]
Site: www.phytoplenus.com
Made in Brazil
Responsible TechnicianEstevan Bruginski / CRF-PR Nº 23447
FormLiquid
PackagingHigh-density polyethylene (HDPE) bottle with sealable lid in 250 ml, 500 ml, and 1000 ml sizes.
CompositionEchinacea purpurea (L.) Moench 6%
Excipients: BHT (Butylated hydroxytoluene), ethanol, citric acid, polyethylene glycol, purified water.
IndicationsExtract for dermic compounded preparations used as anti-inflammatory and immune stimulation agent for healing skin and mucosae lesions.
Instructions for Compounding Medications Based on Phytoplenus Hydroglycolic Extract of Echinacea purpurea 6%Phytoplenus Hydroglycolic Extract of Echinacea purpurea 6% must be prepared at compounding pharmacies which is accredited and certified by Phytoplenus in accordance with current health regulations.
For greater efficacy of the preparations, it is recommended that compounded formulations made from Phytoplenus Hydroglycolic Extract of Echinacea purpurea 6% be diluted with purified water to a concentration of 3%.
Would you like more information? Fill out the form and submit your request. We will contact you as soon as possible.